Paper Details

  1. Home
  2. Paper Details

Pregabalin add-on for drug-resistant partial epilepsy.

Author: HemmingK, LozsadiD, MarsonA G

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Epilepsy is a common neurological condition affecting about 1% of people in the UK. One-third of people with epilepsy continue to have seizures despite medication. To improve outcomes, new antiepileptic drugs have been developed, including pregabalin.
Paper Details　
Original Abstract of the Article :
Epilepsy is a common chronic neurological disease with an estimated prevalence of 1% in the United Kingdom. Approximately a third of these people continue to have seizures despite drug treatment. In order to try to improve outcomes a number of new antiepileptic drugs have been developed and pregabal...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/18254084

データ提供：米国国立医学図書館（NLM）

Pregabalin: A Potential Oasis in the Desert of Epilepsy Treatment

Epilepsy, a chronic neurological disorder, affects millions of people worldwide. This article explores the potential of pregabalin, a novel antiepileptic drug, as an add-on therapy for patients with drug-resistant partial epilepsy. The article provides an overview of the challenges associated with treating drug-resistant epilepsy and the potential role of pregabalin in improving patient outcomes.

Pregabalin Shows Promise for Drug-Resistant Epilepsy

The article highlights the significant unmet need for effective treatments for drug-resistant epilepsy. Pregabalin, like a desert oasis, offers a potential solution for patients who have not responded to traditional antiepileptic medications. The article suggests that pregabalin may be a valuable addition to the therapeutic arsenal for managing drug-resistant epilepsy, offering hope for improved seizure control and quality of life for patients.

Navigating the Desert of Epilepsy Management

This article underscores the importance of personalized treatment strategies for epilepsy. Like a skilled desert navigator, clinicians must carefully select the most appropriate medication regimen for each patient, taking into account their individual needs, risk factors, and response to treatment.

Dr. Camel's Conclusion

Pregabalin emerges as a potential oasis in the desert of epilepsy treatment, offering hope for patients struggling with drug-resistant seizures. However, like a desert mirage, further research is needed to fully understand the long-term efficacy and safety profile of this medication. The search for effective treatments for epilepsy continues, and pregabalin may play a vital role in improving patient outcomes.

Date :
  1. Date Completed 2008-04-14
  2. Date Revised 2021-10-27
Further Info :

Pubmed ID

18254084

DOI: Digital Object Identifier

EMS57588

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.